ClinicalTrials.gg

Program

Benzoyl Peroxide

Also written as “Adapalene/Benzoyl Peroxide”, “Adapalene and Benzoyl Peroxide Gel” and “Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5%”.

Its studies are mostly in Acne Vulgaris · Herpes Simplex · Skin Diseases, led by 7 companies.

Furthest: phase 4, since Feb 4, 200928 company-led studies, 1 open or runningNext primary completion: Jan 2027 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
GlaxoSmithKline90 open or runningphase 4since Feb 4, 2009Jul 7, 2008none ahead
Galderma Group70 open or runningphase 4since Apr 30, 2008Jan 11, 2007none ahead
Sun Pharmaceutical Industries40 open or runningphase 1since Dec 3, 2012Dec 3, 2012none ahead
Teva Pharmaceutical Industries30 open or runningphase 3since Feb 7, 2013Feb 7, 2013none ahead
Padagis20 open or runningphase 3since Jul 31, 2015Jul 31, 2015none ahead
Zurita Laboratorio Farmaceutico Ltda.20 open or runningphase 4since Dec 13, 2010Apr 6, 2009none ahead
Greg Bew11 open or runningphase 2since Jun 16, 2025Jun 16, 2025Jan 2027phase 2 · NCT07032649

Also a collaborator on its studies: proinnovera-gmbh, rho-inc and quintiles-inc.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 14 studies since Jan 11, 2007.

  1. Jun 16, 2011Phase 1 study in Acne VulgarisGlaxoSmithKline · NCT01428466 · 20 enrolled · Japan
  2. Dec 3, 2012Sun Pharmaceutical Industries's first study: phase 1 study in Acne VulgarisNew to Sun Pharmaceutical IndustriesSun Pharmaceutical Industries · NCT01742637 · 2,008 enrolled
  3. Jan 14, 2013Phase 1 study in Acne VulgarisSun Pharmaceutical Industries · NCT01769235 · 1,215 enrolled
  4. Feb 7, 2013Teva Pharmaceutical Industries's first study: phase 3 study in Acne VulgarisNew to Teva Pharmaceutical IndustriesTeva Pharmaceutical Industries · NCT01788384 · 708 enrolled
  5. Jan 30, 2014Phase 4 study in Skin DiseasesGlaxoSmithKline · NCT02052752 · 90 enrolled · United States
  6. Feb 20, 2014Phase 2 study in Acne VulgarisGalderma Group · NCT02073461 · 236 enrolled · Japan
  7. Jul 31, 2015Padagis's first study: phase 3 study in Acne VulgarisNew to PadagisPadagis · NCT02515305 · 890 enrolled · United States
  8. Aug 14, 2015Phase 3 study in Acne VulgarisPadagis · NCT02525549 · 903 enrolled
  9. Oct 14, 2015Phase 1 study in Acne VulgarisSun Pharmaceutical Industries · NCT02578043 · 844 enrolled
  10. Oct 23, 2015Phase 4 study in Acne VulgarisGalderma Group · NCT02589405 · 50 enrolled · Germany
  11. Nov 1, 2015Phase 1 study in Acne VulgarisSun Pharmaceutical Industries · NCT02595034 · 1,000 enrolled
  12. Nov 25, 2015Phase 3 study in Acne VulgarisTeva Pharmaceutical Industries · NCT02616614 · 862 enrolled · United States
  13. Jan 5, 2016Phase 3 study in Acne VulgarisTeva Pharmaceutical Industries · NCT02651220 · 1,001 enrolled · United States, Belize
  14. Jun 16, 2025Greg Bew's first study: phase 2 study in Herpes SimplexNew to Greg BewGreg Bew · NCT07032649 · 100 planned · United States

Ahead

  1. Jan 2027Primary completion: phase 2 study in Herpes SimplexGreg Bew · NCT07032649

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 28 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT07032649Herpes Simplex · United States2Not yet recruitingGreg BewJan 2027100
NCT02651220Acne Vulgaris · United States, Belize3CompletedTeva Pharmaceutical IndustriesApr 20161,001
NCT02616614Acne Vulgaris · United States3CompletedTeva Pharmaceutical IndustriesOct 2015862
NCT02595034Acne Vulgaris1CompletedSun Pharmaceutical IndustriesOct 20151,000
NCT02589405Acne Vulgaris · Germany4CompletedGalderma GroupJan 201650
NCT02578043Acne Vulgaris1CompletedSun Pharmaceutical IndustriesAug 2015844
NCT02525549Acne Vulgaris3CompletedPadagisAug 2012903
NCT02515305Acne Vulgaris · United States3CompletedPadagisApr 2016890
NCT02073461Acne Vulgaris · Japan2CompletedGalderma GroupOct 2014236
NCT02052752Skin Diseases · United States4CompletedGlaxoSmithKlineMay 201490
NCT01788384Acne Vulgaris3CompletedTeva Pharmaceutical IndustriesDec 2012708
NCT01769235Acne Vulgaris1CompletedSun Pharmaceutical IndustriesSep 20131,215
NCT01742637Acne Vulgaris1CompletedSun Pharmaceutical IndustriesFeb 20142,008
NCT01428466Acne Vulgaris · Japan1CompletedGlaxoSmithKlineFeb 15, 201120
NCT01260571Treatment of Acne Vulgaris Grade II in a Short Period of Time. · Brazil4UNKNOWNZurita Laboratorio Farmaceutico Ltda.Mar 201162
NCT01138735Acne Vulgaris · United States, Canada4CompletedGalderma GroupAug 2011285
NCT00964366Acne Vulgaris · United States4CompletedGlaxoSmithKlineAug 200953
NCT00964223Acne Vulgaris · United States4CompletedGlaxoSmithKlineNov 200928
NCT00926367Acne Vulgaris · United States4CompletedGlaxoSmithKlineJun 200952
NCT00887484Acne Vulgaris · Argentina4CompletedGlaxoSmithKlineJun 200950
NCT00877409Acne Vulgaris · Brazil3UNKNOWNZurita Laboratorio Farmaceutico Ltda.Jul 200980
NCT00837213Acne Vulgaris · United States4CompletedGlaxoSmithKlineAug 200833
NCT00776919Acne Vulgaris · United States, Belize, Canada3CompletedGlaxoSmithKlineSep 20091,315
NCT00713609Acne Vulgaris · United States2CompletedGlaxoSmithKlineMar 2009591
NCT00671749Acne Vulgaris · United States4CompletedGalderma GroupAug 2008100
NCT00446043Acne Vulgaris · United States3CompletedGalderma GroupMay 23, 2005452
NCT00422240Acne Vulgaris · United States3CompletedGalderma GroupJul 12, 20071,668
NCT00421993Acne Vulgaris · United States, Canada, Germany and more3CompletedGalderma GroupOct 20071,670

How it is read

Names in the registry

  • “Adapalene/Benzoyl Peroxide”, 3 entries
  • “Adapalene and Benzoyl Peroxide Gel”, 2 entries
  • “Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5%”, 2 entries
  • “Benzoyl Peroxide 10% Bar”, 1 entry
  • “Benzoyl Peroxide Gel 2.5%”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.